![[Pack of 2] Multi Collagen Supplements for Women - 10,000mg Type I, II, III, V & X Hydrolysed Marine Collagen Powder, Bovine Collagen, Egg & Cartilage Collagen Peptides for Skin, Hair, Nails & Joints](https://m.media-amazon.com/images/I/61yBhnLdFNL._AC_SY145_.jpg)
这个市场不值得进入,结论很明确:样本里没有可复制的盈利窗口,反而是低差异化、低利润、强竞争的失败市场。 目前可识别的新品牌是 0,新发布产品是 0,整体盈利产品占比也是 0%;唯一出现的老品牌 Inspiriko 只有 2 个样本 ASIN,全部都不盈利,说明这里不是“选品没选对”那么简单,而是赛道本身就很难跑通。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这不是一个可进入的市场。 目前样本里可识别的盈利产品占比是0.00%,新发布产品盈利占比也是0%,而且唯一能看到的对标品牌 Inspiriko 只有2个样本产品,全部都不盈利,说明这里已经不是“怎么做更好”的问题,而是“连基本利润都很难守住”的问题。再叠加你给出的预算,虽然能覆盖前期上架与首月投放,但不足以支撑后续研发、品牌和认证投入,所以不建议继续。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不适合进入,结论很明确:没有可复制的成功样本,反而是低利润、低活跃、同质化的失败市场。 当前样本里可识别的盈利产品比例为0.00%,新上架产品的盈利比例也是0;再看现成案例,Inspiriko 的两款核心 ASIN 都是非盈利,而且都是老产品、非活跃销售,说明这个赛道靠普通跟款很难跑通。
这不是一个适合新品牌进入的市场:样本里可见产品只有2个,全部来自老品牌 Inspiriko,且没有任何新品牌、新发布产品或可识别的盈利新进入者,说明这个细分里几乎没有给小品牌留下真实窗口。 现有产品中 B0D92KGV76 只做到 13.4% 利润率、22 条评论、且销售状态是 inactive;B0DJVGF9DS 也没有可见盈利数据。按你给的标准,这已经接近低利润、弱需求、强竞争的危险区,不是值得押注的赛道。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
![]() | B0D92KGV76 | Inspiriko | 2024-07-07 | No | £25.99 | -pcs | £- | 13.35% | £- |
![]() | B0DJVGF9DS | Inspiriko | 2024-10-11 | No | £- | -pcs | £- | -% | £- |
结论很直接:这个市场不值得进入,属于明显的价格战/低质量竞争区,不论大品牌还是小企业都不应贸然进场。 目前可识别样本里,整体可盈利比例为0%,新品牌可盈利比例也是0%,而且市场里只有老牌 Inspiriko 一家在样本中出现,说明不是“新人可切入”的开放市场,而是已经被既有品牌和同质化产品锁死的市场。
这个市场不适合进入:当前样本里只有 1 个已识别老品牌 Inspiriko,且 2 个样本 ASIN 全部亏损,市场可识别盈利率为 0%,新上架产品盈利率也是 0%。更关键的是,近期开新与盈利时间数据几乎为空,说明不是“还能捡漏”的阶段,而是样本已显露出低差异化、低利润、难以盈利的状态。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |